| Name | Title | Contact Details |
|---|
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
Global Clinical Trials is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Accent On Health is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vertebral Technologies, Inc. is a Minnetonka, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nutrition isn`t complicated. For us, it`s natural. We`ve been a leader in the research and development of carotenoid-based products for the last two decades and we take that role very seriously. This means we approach everything we do with a sense of wonder and a driving desire to find the best possible outcome or create the highest-quality product.